Otolaryngology manifestations of COVID-19 in pediatric patients
- PMID: 33845420
- PMCID: PMC8011029
- DOI: 10.1016/j.ijporl.2021.110701
Otolaryngology manifestations of COVID-19 in pediatric patients
Abstract
Background: The coronavirus disease 2019 pandemic has affected millions of people since its outbreak in December 2019. Limited data exist on otolaryngology manifestations of COVID-19 in pediatrics. This study aims to discuss the clinical features of COVID-19 in pediatrics, with an emphasis on otolaryngology manifestations.
Methods: The study included 660 COVID-19 laboratory-confirmed positive pediatric patients (aged 3-15 years) diagnosed at King Abdullah Specialist Children Hospital, Riyadh, Saudi Arabia. Data were retrospectively retrieved from January to July 2020 from electronic medical records and included patients' epidemiological and clinical features. Patients were then followed-up via phone calls to document any symptoms encountered after the first visit. Patients were categorized into three main groups according to age (3-6 years, 7-10 years, 11-15 years).
Results: Nearly half of the patients (43.6%) had asymptomatic infections. Fever and cough were the most commonly reported manifestations accounting for 39.2% and 19.8%, respectively. The most frequently reported otolaryngology symptoms were sore throat (17.3%) and rhinorrhea (14.4%). Moreover, 10.4% and 13.1% of children aged 7-15 years old experienced smell and taste disturbances, respectively. Older children (11-15 years) were more likely to report taste disturbances when compared to the younger children (17.2% vs 9.8%, p-value 0.02). Children aged between 3 and 6 years had significantly higher rates of admission (13.7%) and mortality (0.9%) when compared to the older groups (p-value 0.00).
Conclusion: COVID-19 in pediatrics has a milder disease course and a better prognosis than adults. Multiple otolaryngology symptoms were reported in pediatric patients with COVID-19, which can help identify the suspected cases before the test result.
Keywords: COVID-19; Otolaryngology; Pediatric; Smell; Taste.
Copyright © 2021 Elsevier B.V. All rights reserved.
Similar articles
-
A structural equation model to examine the clinical features of mild-to-moderate COVID-19: A multicenter Italian study.J Med Virol. 2021 Feb;93(2):983-994. doi: 10.1002/jmv.26354. Epub 2020 Aug 2. J Med Virol. 2021. PMID: 32710639
-
Otolaryngology-Specific Symptoms May Be Highly Observed in Patients With a History of Covid-19 Infection After Inactivated Coronavirus Vaccination.Ear Nose Throat J. 2023 Nov;102(11):715-719. doi: 10.1177/01455613211028493. Epub 2021 Jul 8. Ear Nose Throat J. 2023. PMID: 34233498
-
Ear, Nose, and Throat Manifestations of COVID-19 in Children.Pediatr Ann. 2021 Jul;50(7):e277-e281. doi: 10.3928/19382359-20210613-01. Epub 2021 Jul 1. Pediatr Ann. 2021. PMID: 34264800 Review.
-
Prevalence of Loss of Smell and/or Taste and other Otorhinolaryngology Symptoms in COVID-19 Patients.Kathmandu Univ Med J (KUMJ). 2021 Apr-Jun;19(74):173-179. Kathmandu Univ Med J (KUMJ). 2021. PMID: 34819431
-
[Taste and smell loss in patients with COVID-19].Ugeskr Laeger. 2020 Aug 31;182(36):V06200442. Ugeskr Laeger. 2020. PMID: 33000727 Review. Danish.
Cited by
-
Evaluation of the Peripheral and Central Auditory Systems in Children and Adolescents Before and After COVID-19 Infection.Children (Basel). 2024 Nov 28;11(12):1454. doi: 10.3390/children11121454. Children (Basel). 2024. PMID: 39767883 Free PMC article.
-
Audiological and vestibular symptoms following SARS-CoV-2 infection and COVID-19 vaccination in children aged 5-11 years.Am J Otolaryngol. 2023 Jan-Feb;44(1):103669. doi: 10.1016/j.amjoto.2022.103669. Epub 2022 Oct 20. Am J Otolaryngol. 2023. PMID: 36283164 Free PMC article.
-
Epidemiology and clinical features of SARS-CoV-2 infection in children and adolescents in the pre-Omicron era: A global systematic review and meta-analysis.J Glob Health. 2024 Mar 1;14:05003. doi: 10.7189/jogh.14.05003. J Glob Health. 2024. PMID: 38419461 Free PMC article.
-
Six clinical phenotypes with prognostic implications were identified by unsupervised machine learning in children and adolescents with SARS-CoV-2 infection: results from a German nationwide registry.Respir Res. 2024 Oct 30;25(1):392. doi: 10.1186/s12931-024-03018-3. Respir Res. 2024. PMID: 39478555 Free PMC article.
-
Prognosis of COVID-19 in the middle eastern population, knowns and unknowns.Front Microbiol. 2022 Aug 31;13:974205. doi: 10.3389/fmicb.2022.974205. eCollection 2022. Front Microbiol. 2022. PMID: 36118201 Free PMC article. Review.
References
-
- WHO . 2021. Coronavirus Disease (COVID-19) – World Health Organization.https://www.who.int/emergencies/diseases/novel-coronavirus-2019 [cited 2021 January, 8]; Available from: - PubMed
-
- Wu Z., McGoogan J.M. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese center for disease control and prevention. J. Am. Med. Assoc. 2020;323(13):1239–1242. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical